Bruker Corp
NASDAQ:BRKR

Watchlist Manager
Bruker Corp Logo
Bruker Corp
NASDAQ:BRKR
Watchlist
Price: 57.07 USD 1.51% Market Closed
Market Cap: 8.7B USD
Have any thoughts about
Bruker Corp?
Write Note

Intrinsic Value

The intrinsic value of one BRKR stock under the Base Case scenario is 70.32 USD. Compared to the current market price of 57.07 USD, Bruker Corp is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BRKR Intrinsic Value
70.32 USD
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bruker Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BRKR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BRKR?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Bruker Corp

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bruker Corp

Provide an overview of the primary business activities
of Bruker Corp.

What unique competitive advantages
does Bruker Corp hold over its rivals?

What risks and challenges
does Bruker Corp face in the near future?

Has there been any significant insider trading activity
in Bruker Corp recently?

Summarize the latest earnings call
of Bruker Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bruker Corp.

Provide P/S
for Bruker Corp.

Provide P/E
for Bruker Corp.

Provide P/OCF
for Bruker Corp.

Provide P/FCFE
for Bruker Corp.

Provide P/B
for Bruker Corp.

Provide EV/S
for Bruker Corp.

Provide EV/GP
for Bruker Corp.

Provide EV/EBITDA
for Bruker Corp.

Provide EV/EBIT
for Bruker Corp.

Provide EV/OCF
for Bruker Corp.

Provide EV/FCFF
for Bruker Corp.

Provide EV/IC
for Bruker Corp.

Show me price targets
for Bruker Corp made by professional analysts.

What are the Revenue projections
for Bruker Corp?

How accurate were the past Revenue estimates
for Bruker Corp?

What are the Net Income projections
for Bruker Corp?

How accurate were the past Net Income estimates
for Bruker Corp?

What are the EPS projections
for Bruker Corp?

How accurate were the past EPS estimates
for Bruker Corp?

What are the EBIT projections
for Bruker Corp?

How accurate were the past EBIT estimates
for Bruker Corp?

Compare the revenue forecasts
for Bruker Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bruker Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bruker Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bruker Corp compared to its peers.

Compare the P/E ratios
of Bruker Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Bruker Corp with its peers.

Analyze the financial leverage
of Bruker Corp compared to its main competitors.

Show all profitability ratios
for Bruker Corp.

Provide ROE
for Bruker Corp.

Provide ROA
for Bruker Corp.

Provide ROIC
for Bruker Corp.

Provide ROCE
for Bruker Corp.

Provide Gross Margin
for Bruker Corp.

Provide Operating Margin
for Bruker Corp.

Provide Net Margin
for Bruker Corp.

Provide FCF Margin
for Bruker Corp.

Show all solvency ratios
for Bruker Corp.

Provide D/E Ratio
for Bruker Corp.

Provide D/A Ratio
for Bruker Corp.

Provide Interest Coverage Ratio
for Bruker Corp.

Provide Altman Z-Score Ratio
for Bruker Corp.

Provide Quick Ratio
for Bruker Corp.

Provide Current Ratio
for Bruker Corp.

Provide Cash Ratio
for Bruker Corp.

What is the historical Revenue growth
over the last 5 years for Bruker Corp?

What is the historical Net Income growth
over the last 5 years for Bruker Corp?

What is the current Free Cash Flow
of Bruker Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bruker Corp.

Business Breakdown

Bruker Corporation stands as a pivotal player in the life sciences and analytical instrument markets, renowned for its innovative technologies that empower researchers and laboratories worldwide. Founded in 1960, Bruker has consistently focused on developing advanced scientific instruments that enhance the understanding of biological processes and materials. Through its diverse portfolio, which includes high-performance mass spectrometry, nuclear magnetic resonance (NMR), and microscopy systems, Bruker addresses critical challenges in fields such as drug discovery, environmental analysis, and clinical diagnostics. With a commitment to innovation, the company is well-positioned to benefit fro...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bruker Corp

Current Assets 2.2B
Cash & Short-Term Investments 148.1m
Receivables 712.9m
Other Current Assets 1.3B
Non-Current Assets 3.9B
PP&E 841.4m
Intangibles 2.5B
Other Non-Current Assets 579m
Current Liabilities 1.3B
Accounts Payable 227.5m
Other Current Liabilities 1.1B
Non-Current Liabilities 3B
Long-Term Debt 2.3B
Other Non-Current Liabilities 719.3m
Efficiency

Earnings Waterfall
Bruker Corp

Revenue
3.2B USD
Cost of Revenue
-1.6B USD
Gross Profit
1.6B USD
Operating Expenses
-1.2B USD
Operating Income
370.3m USD
Other Expenses
-65.4m USD
Net Income
304.9m USD

Free Cash Flow Analysis
Bruker Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Bruker reported a 16.4% increase in revenue to $864 million, with 3.1% organic growth. Challenges remain, particularly in biopharma and China, prompting a revenue guidance adjustment to $3.34-$3.37 billion and 3-4% organic growth. Non-GAAP EPS fell to $0.60, down 18.9%, while operating margins decreased to 14.9%. Looking ahead, Bruker expects low single-digit organic growth for Q4 but aims for significant margin improvement and above-market growth in 2025 amid stimulus-driven demand recovery in China and ongoing strong performance in diagnostics and semiconductor tools.

What is Earnings Call?
Fundamental Scores

BRKR Profitability Score
Profitability Due Diligence

Bruker Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive 3-Years Revenue Growth
59/100
Profitability
Score

Bruker Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

BRKR Solvency Score
Solvency Due Diligence

Bruker Corp's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Average Altman Z-Score
Long-Term Solvency
Average D/E
48/100
Solvency
Score

Bruker Corp's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BRKR Price Targets Summary
Bruker Corp

Wall Street analysts forecast BRKR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRKR is 74.47 USD with a low forecast of 54.54 USD and a high forecast of 89.25 USD.

Lowest
Price Target
54.54 USD
4% Downside
Average
Price Target
74.47 USD
30% Upside
Highest
Price Target
89.25 USD
56% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BRKR?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BRKR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BRKR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

BRKR News

Other Videos

Profile

Bruker Corp Logo
Bruker Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

8.7B USD

Dividend Yield

0.35%

Description

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 7,765 full-time employees. The company went IPO on 2000-08-04. The firm operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

Contact

MASSACHUSETTS
Billerica
40 Manning Rd
+19786633660.0
www.bruker.com

IPO

2000-08-04

Employees

7 765

Officers

Chairman, CEO & President
Dr. Frank H. Laukien Ph.D.
Executive VP & CFO
Mr. Gerald N. Herman
Corporate Executive VP and President of Bruker Nano Group & Corporate
Dr. Mark R. Munch Ph.D.
President of Bruker CALID Group & Bruker Daltonics Division
Mr. Juergen Srega
President of Bruker BioSpin Group
Dr. Falko Busse Ph.D.
Senior Director of Investor Relations & Corporate Development
Mr. Justin Joseph Ward
Show More
General Counsel & Secretary
Mr. J. Brent Alldredge J.D.
President and CEO of Bruker Energy & Supercon Technologies, Inc.
Dr. Burkhard Prause Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BRKR stock?

The intrinsic value of one BRKR stock under the Base Case scenario is 70.32 USD.

Is BRKR stock undervalued or overvalued?

Compared to the current market price of 57.07 USD, Bruker Corp is Undervalued by 19%.

Back to Top